|
| Press Releases |
|
 |
|
| Friday, October 19, 2018 |
|
|
Novotech and CNS deal expands CRO services for Biopharma Clients across Asia-Pacific |
| Novotech, the largest Asia-Pacific-based CRO, has acquired Australasian specialist CRO Clinical Network Services (CNS), as part of a mutual mission to expand services to biopharma for early phase product development and clinical research through to later phase regional and global trials. more info >> |
|
| Thursday, August 23, 2018 |
|
|
Novotech the Asia-Pacific CRO named Top 10 CRO |
| Asia-Pacific specialist CRO Novotech has been selected as one of the Top 10 CROs globally by leading industry media magazine Pharma Tech Outlook. more info >> |
|
| Thursday, August 9, 2018 |
|
|
Sponsors Recommend Novotech for CRO Leadership Award |
| Asia-Pacific specialist CRO Novotech has been awarded the "Exceeded Customer Expectations" Award by Life Science Leader magazine based on findings from sponsor companies that utilise outsourcing services. In particular, Novotech was recognised for its local market/regulatory knowledge and for meeting timelines. more info >> |
|
| Thursday, July 19, 2018 |
|
|
Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical Trials |
| Asia-Pacific specialist CRO Novotech announced today it has partnered with the Asian Eye Institute Inc (AEI), a private eye center in the Philippines, to facilitate high-quality and rapid feasibility, start-up and recruitment processes for its ophthalmology clients. more info >> |
|
| Thursday, June 28, 2018 |
|
|
Novotech at DIA18 announces Asia Partnerships on Target to Reach 1.4 Bil Patients |
| Asia-Pacific CRO Novotech announced today at DIA Global Annual Meeting (24-28 June, Boston Convention and Exhibition Center) that it has signed Memorandum of Understandings (MOU) with five of the leading medical institutions in the region. more info >> |
|
| Friday, June 15, 2018 |
|
|
Novotech signs MoU with CMUH Taiwan to offer Enhanced Services for Global Trials |
| Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MoU) with the China Medical University Hospital (CMUH) in Taiwan to facilitate high-quality and rapid feasibility, start-up and recruitment processes. http://www.cmuh.cmu.edu.tw/ more info >> |
|
| Monday, June 18, 2018 |
|
|
Novotech與中國醫藥大學附設醫院 (台灣) 締結MOU為全球試驗提供增效服務 |
| 亞太專業級合約研究機構(CRO) Novotech今日宣布已與中國醫藥大學附設醫院(CMIUH，台灣)締結一份諒解備忘錄(MOU)，旨在助力高質量、快速的項目可行性研究、啟動和招募流程。 http://www.cmuh.cmu.edu.tw more info >> |
|
| Tuesday, June 12, 2018 |
|
|
Novotech与中国医药大学附设医院（台湾）缔结MOU为全球试验提供增效服务 |
| 亚太专业级合约研究机构(CRO) Novotech今日宣布已与中国医药大学附设医院(CMIUH，台湾)缔结一份谅解备忘录(MOU)，旨在助力高质量、快速的项目可行性研究、启动和招募流程。http://www.cmuh.cmu.edu.tw more info >> |
|
|
Novotech Signs MOU with China Medical University Hospital in Taiwan to Offer Enhanced Services for Global Trials |
| Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with the China Medical University Hospital (CMUH) in Taiwan to facilitate high-quality and rapid feasibility, start-up and recruitment processes. http://www.cmuh.cmu.edu.tw/ more info >> |
|
| Friday, May 18, 2018 |
|
|
Novotech稱，聯邦預算研發稅收扶持使澳大利亞在高質量臨床試驗方面具有全球競爭力 |
| 亞太地區首席技術官對特恩布爾政府的聯邦預算決定表示讚賞。該決定將臨床試驗活動排除在400萬美元的現金退款限製或最大封頂限額之外。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AdsDrama Launches Short-Drama Marketing Ecosystem Launch in the Dominican Republic, Paving the Way for Digital Content Innovation
Mar 14, 2026 05:00 HKT/SGT
|
|
|
General MRO Aerospace 取得中國民航局認證，拓展全球維修能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace 获得中国民航局认证，拓展全球维护能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace Achieves CAAC Certification, Expanding Global Maintenance Capabilities
Mar 13, 2026 22:20 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00: JST
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00 HKT/SGT
|
|
|
CITIC Resources Deepens Dual-Engine Strategy of 'Investment + Trading', Continues to Promote High-Quality Development
Mar 13, 2026 21:01 HKT/SGT
|
|
|
中信資源深化「投資+貿易」雙輪戰略 持續驅動高質量發展 推進「上游資產布局、貿易業務拓展、生產運營提質」
Mar 13, 2026 20:53 HKT/SGT
|
|
|
中信资源深化「投资+贸易」双轮战略 持续驱动高质量发展 推进「上游资产布局、贸易业务拓展、生产运营提质」
Mar 13, 2026 20:40 HKT/SGT
|
|
|
康哲藥業：腎性貧血新藥德昔度司他片中國獲批上市
Mar 13, 2026 20:24 HKT/SGT
|
|
|
康哲药业：肾性贫血新药德昔度司他片中国获批上市
Mar 13, 2026 20:15 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 18:00: JST
|
|
|
uSMART HK Expands to 12 Physical Service Centres in One Year, Accelerating "Online x Offline" O2O Community Finance Strategy
Mar 13, 2026 17:34 HKT/SGT
|
|
|
盈立證券一年拓展12個服務網點 全力深化「線上x線下」O2O社區金融佈局
Mar 13, 2026 17:21 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 17:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
